1 / 14

Technology Transfer at CU-Boulder

Technology Transfer at CU-Boulder. Kate Tallman Licensing Associate kate.tallman@colorado.edu. Liza Eschbach Licensing Associate liza.eschbach@colorado.edu. Mary Tapolsky Licensing Associate mary.tapolsky@colorado.edu. Annalissa Philbin Research Contracts annalissa.philbin@cu.edu.edu.

tova
Download Presentation

Technology Transfer at CU-Boulder

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Technology Transfer at CU-Boulder Kate Tallman Licensing Associate kate.tallman@colorado.edu Liza Eschbach Licensing Associate liza.eschbach@colorado.edu Mary Tapolsky Licensing Associate mary.tapolsky@colorado.edu Annalissa Philbin Research Contracts annalissa.philbin@cu.edu.edu Ken Porter Director ken.porter@colorado.edu www.cu.edu/techtransfer303.492.5647 4001 Discovery Drive, Stuite 390 Quest Building | Innovation | Knowledge Technology

  2. TTO Serviceswww.cu.edu/techtransfer • CDAs, MTAs • SRAs – IP terms only • CU owns new IP • Limited-term exclusive option to Sponsor • Patenting/licensing • Education • Seminars: IP, start-up (internal & external) • Interns: “Learning Laboratory” • Bulletins: Tech Transfer How-to

  3. Basic Tenets of Regent Patent Policy www.cu.edu/techtransfer • Presumption that University owns IP created by employees, or by use of CU facilities • Narrow circumstances create a few exemptions to this presumption, which includes students working in CU courses • Acknowledges cooperation between inventor and technology transfer is necessary for success • Faculty Oversight Committee created • Division of income stipulated – 4 x 25*

  4. IP Generated by non-FederalSponsored Research at CU-Boulder • Employees assign IP to CU as a condition of employment • Expectation for sponsor to commercialize inventions • IP conveyed to sponsor via license • Six month option with no fee other than reimbursement for patent costs • Patent claims tailored to fit sponsor’s anticipated application • 25% of operating profit returned to CU

  5. Participants TechnologyTransfer TTO Process Market, Patent Inventor Industry Align interests IDF Invention $$ Expertise Access License

  6. The Tech Transfer ProcessInvention Disclosurewww.cu.edu/techtransfer/campus/idf.html • Inventors • Technical Description • Evidence for Patent • www.uspto.gov/patft/index.html • Novelty, Non-obviousness, Utility • Public Disclosure • Sponsorship

  7. Invention Timeline: Conception to Patent Protection $10 3 $10 4 $10 5 PTO File US Patent File PCT Provisional Patent PCT National Phase Priority 12 30 Date months months TTO Invention Disclosure Form (IDF) Provisional Patent Marketing and Patenting Licensing Research Observation Hypothesis Prediction Experimentation INVENTION

  8. Input Comparison with Peers Output

  9. Performance Metrics Disclosures85% increase02-05 / 97-01 Revenue 143% increase02-05 / 96-01

  10. Comparison with Peers

  11. Summary Statistics Yr 1 Yr 2 Yr 3

  12. Disclosures by Department

  13. Boulder Start-ups 2004 ALD NanoSolutions Steve George (Chem E) Particle ALD, R&D 100 awardAl Weimer (Chem E) AlphaSniffer Dana Anderson (Physics) Optical nose, privately fundedVictor Bright (Mech E) Cardiac Access Roop Mahajan (Mech E) Smart stethoscope, option converted to license KM Labs Margaret Murnane (Physics) Amplifier for ultrafast lasersHenry Kapteyn (Physics) Meridian Water JoAnn Silverstein (Civil E) Biological denitrification of water, privately funded MRT Mark Hernandez (Civil E) Metal removal technology, reincorporated as Xenopure Sentry Biosciences Ding Xue (MCDB) Drug targets for control of apoptosis

  14. TTO Missionwww.cu.edu/techtransfer • Faculty service • Support the CU research mission • Education • Economic development • Internal: licensing and research $$ • External: company formation, job creation

More Related